Cedar entrepreneur Ray Pleva reports that scientists at Central Michigan University have found evidence suggesting that products he is developing may benefit those seeking treatment for common neurological diseases.

Researchers Gary Dunbar and Justin Oh-Lee have completed a year of research that focused on assessing behavioral improvements in animal models of Alzheimer’s, Huntington’s and Parkinson’s diseases by using antioxidants in tart cherries and Omega-3 essential fatty acids from emu and fish oils found in Pleva’s Cerise Neutraceuticals.

The research suggests benefits for helping to improve balance and motor functions, counteracting movement disorders and reducing oxidative stress and side effects, providing a safer way for treating the disorders. Further research will be required to demonstrate therapeutic potential for clinical development and human trials, Pleva said.

An application for a second year of research has been submitted to provide a more comprehensive assessment of the Cerise project, using the Parkinson’s, Alzheimer’s and Huntington disease models.

Pleva said the new life science research could lead to improvements in health and wellness while helping the cherry industry at the same time.